Tag: Meningitis
Universal Vaccination for MenB at College Entry Not Cost-Effective
Incremental cost per quality-adjusted life-year gained $13.8 million under societal perspective
Physicians Lack Knowledge About Serogroup MenB Vaccination
Primary care docs who are somewhat or not aware of MenB vaccine are less likely to discuss vaccination
Viruses ID’d As Most Common Cause of Meningitis in U.K. Adults
Estimated annual incidence of viral meningitis is 2.73 per 100,000 U.K. adults
Bivalent Meningococcal B Vaccine Safe, Immunogenic
Elicits bactericidal responses against diverse meningococcal B strains in teens, young adults
Meningitis After Vaccination in Eculizumab Recipients
Sixteen cases of meningococcal disease reported in eculizumab recipients during 2008 to 2016
Effectiveness of One-Dose MenACWY-D Drops Over Time
Effectiveness 79 percent at less than one year, drops to 61 percent at three to less than eight years
Bell’s Palsy Tied to Quadrivalent Meningococcal Vaccine
Increased risk for Bell's palsy in those with concomitant administration of other vaccines
Recommendations Updated for Meningococcal Vaccine in HIV
All HIV+ individuals should receive meningococcal conjugate vaccine (serogroups A, C, W, and Y)
Seropositivity of Meningitis B Vaccine Lower Than Expected
One in three students didn't get immunity against outbreak strain after two doses
Dexamethasone No Help in HIV-Linked Cryptococcal Meningitis
Dexamethasone doesn't reduce mortality; linked to higher percentage of patients with disability
